Form 4: TELA Bio Director Receives Equity Compensation
Statement of Changes in Beneficial Ownership
Director Guy P. Nohra was granted restricted stock units and stock options as part of TELA Bio's equity incentive plan.
Summary
- Director Guy P. Nohra acquired 11,925 restricted stock units (RSUs) vesting over three years.
- Director Guy P. Nohra acquired 11,675 RSUs vesting on the earlier of June 9, 2027, the next annual meeting, or a change in control.
- Director Guy P. Nohra was granted 17,550 stock options with an exercise price of $0.935, vesting over 36 months.
- Director Guy P. Nohra was granted 17,335 stock options with an exercise price of $0.935, vesting on the earlier of June 9, 2027, the next annual meeting, or a change in control.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- Potential for future shareholder dilution upon the exercise of stock options and vesting of RSUs.
Risks
- Continued service requirements for vesting may impact director retention.
- Market price volatility could affect the value of the granted equity.
Future Outlook
The equity grants are subject to continued service requirements, aligning the director's tenure with the company's long-term performance goals.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the medical device and biotechnology sectors to ensure board alignment with shareholder interests.
Comparison to Industry Standards
- The use of a mix of RSUs and stock options is consistent with standard compensation packages for directors in small-cap healthcare companies.
- Vesting schedules tied to annual meetings or change-in-control events are common provisions in equity incentive plans for publicly traded firms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Grant | Issuance of equity awards to Director Guy P. Nohra under the 2019 Equity Incentive Plan. | 06/09/2026 | Standard alignment of director compensation with company performance. |
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual exercise of options and vesting of RSUs.
Next Steps
- Vesting of RSUs and options subject to continued service through specified dates.
Key Dates
| Date | Description |
|---|---|
| 06/09/2026 | Date of earliest transaction and grant date for equity awards. |
| 06/11/2026 | Date of filing. |
| 06/09/2027 | Initial vesting date for certain RSUs and options. |
| 06/09/2036 | Expiration date for stock options. |
Keywords
TELA Bio, TELA, Form 4, Director Compensation, Equity Incentive Plan, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.